{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Toronto",
      "state": "",
      "country": "Canada",
      "classification": "Class III",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "67985",
      "recalling_firm": "Apotex Inc.",
      "address_1": "150 Signet Drive",
      "address_2": "",
      "postal_code": "N/A",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide and Puerto Rico.",
      "recall_number": "D-1299-2014",
      "product_description": "Risperidone Oral Solution, 1 mg/mL, 30 mL bottle, Rx only, Manufactured by Apotex Inc., Toronto, Ontario, Canada M9L 1T9, Manufactured for Apotex Corp., Weston, FL 33326, NDC 60505-0380-1.",
      "product_quantity": "11,422 bottles",
      "reason_for_recall": "Failed Impurities/Degradation Specifications: Out of Specification for an impurity at the 18 month stability time point.",
      "recall_initiation_date": "20140320",
      "center_classification_date": "20140501",
      "termination_date": "20141223",
      "report_date": "20140507",
      "code_info": "Lot #: KD4855, Exp 06/14",
      "more_code_info": ""
    }
  ]
}